hair loss glp-1 One of the most common concerns I'm seeing in patients taking medications is loss. For some, it shows up as increased shedding; for others, it can be more dramatic with Hair Loss and GLP-1 Medications

February 3, 2026: Man Sues Ozempic, Claims the Injectable Semaglutide Caused Him to Lose Sight A man from Ohio has filed a legal claim against Ozempics manufacturer, Novo Nordisk, alleging that he developed NAION after taking Ozempic as prescribed

Some compounded programs may offer tirzepatide in oral dissolving tablet form when legally available and clinically appropriate

05.28.25 FDA published updates to Mounjaro warning label The FDA Center for Drug Evaluation and Research (CDER) published newly approved changes to the Mounjaro label

Of the numerous prospective randomized clinical trials evaluating the influence of GLP-1 RA use on cardiovascular outcomes (Table 1), only the ELIXA study of lixisenatide [28] has thus far published its results

Eur J Heart Fail (2017) 19(1):6977

The app combines structured nutrition guidance, light exercise routines, and progress tracking tools to help users navigate weight loss with greater clarity and consistency